Allston Landing's more than 400 employees work around the clock, 365 days a year to ensure that the therapies produced there meet optimal quality standards. Genzyme recruits and trains residents from the local community for a wide range of jobs at the facility, including positions in manufacturing operations, facilities engineering, and quality operations.
The architect for the Allston expansion project is ARC/Architectural Resources Cambridge Inc. and the general contractor is Turner Construction Inc. The engineers are Clark, Richardson & Biskup, Careba Mott MacDonald, and Tetra Tech Rizzo. The project is expected to be completed in approximately two years.
As it has grown internationally, Genzyme has maintained its long-standing commitment to Massachusetts, where the company was founded in 1981. Genzyme has a large and growing presence in the state, which is home to nearly half of the company's approximately 10,000 employees. Genzyme recently completed its new 180,000 square-foot Science Center in Framingham, as well as a 55,000 square-foot expansion of its Waltham location, and the company continues to build its presence in Boston, Cambridge, and Westborough. Genzyme currently occupies more than 2 million square feet of space in Massachusetts. The company has facilities across the United States and in more than 30 countries around the world. Genzyme is conducting major expansion projects in Belgium, France, the United Kingdom, China, and the Netherlands.
|SOURCE Genzyme Corp.|
Copyright©2007 PR Newswire.
All rights reserved